摘要 |
A method of preparation of a medicament for reducing the risk of production of undesirable metabolites from free bodily AA on administration of AA to currect deficiency thereof, wherein GLA and/or DGLA as such or in the form of a salt dissociated at physiological pH is prepared as said medicament alone or incorporated in a pharmaceutically acceptable diluent or carrier. |